What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT05847686 - Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
Clinical Trial in Seattle, Washington
This phase I/II trial tests the safety and side effects of psilocybin in combination with therapy for the treatment of patients with metastatic cancer and symptoms of anxiety and/or depression. Psilocybin is a substance being studied in conjunction with therapy for the treatment of anxiety and depression in patients with cancer. In this study, the psilocybin being used is derived from the mushroom psilocybe cubens... Source record lists lead sponsor University of Washington and overall status Completed.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT05847686
- Last Verified
- 2026-06-12
Location
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT05847686; status Completed; sponsor University of Washington.
Source: https://clinicaltrials.gov/study/NCT05847686
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.